Philip Cohen

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma.

Parkash S. Gill, J Wernz, David T. Scadden et al. · Journal of Clinical Oncology · 1996 · 437 citations

Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma

Katherine Robinson, Michael E. Williams, Richard H. van der Jagt et al. · Journal of Clinical Oncology · 2008 · 352 citations

Circulating Tumor Cells: A Useful Predictor of Treatment Efficacy in Metastatic Breast Cancer

Minetta C. Liu, Peter G. Shields, Robert Warren et al. · Journal of Clinical Oncology · 2009 · 312 citations · Full text

Bendamustine in Patients With Rituximab-Refractory Indolent and Transformed Non-Hodgkin's Lymphoma: Results From a Phase II Multicenter, Single-Agent Study

Jonathan W. Friedberg, Philip Cohen, Ling Chen et al. · Journal of Clinical Oncology · 2008 · 298 citations · Full text

14-3-3 Protein, Neuron-Specific Enolase, and S-100 Protein in Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease

P. Beaudry, Philip Cohen, J.-P. Brandel et al. · Dementia and Geriatric Cognitive Disorders · 1998 · 182 citations

Creutzfeldt-jakob Disease, Neurological Disorder, S-100 Protein +16